Vitamin D deficiency is common in women with PCOS ranged between 67% and 85% as defined serum concentrations of 25-hydroxyvitamin D (25OHD) <20 ng/ml. Vitamin D deficiency may escalate the symptoms of PCOS in women. The lower Vitamin D in PCOS patients has been shown to associate with IR, lower pregnancy rate, ovulatory and menstrual irregularities, hirsutism, elevated cardiovascular disease risk factors, obesity, and hyperandrogenism. [7] Currently, there is limited evidence on the association of Vitamin D levels with PCOS disease. [7, 8] The present study aims to assess the association between serum Vitamin D levels in patients with PCOS compared to healthy controls in Duhok city.
MaterIals and Methods

Research design and sampling
In the present case-control study, the individuals who attended the Gynecology and Obstetrics Clinic of Duhok Maternity Hospital for the medical checkup were consecutively screened for eligibility criteria. The individuals who attended the clinic for the following medical issues; complaining of infertility, obesity, and hirsutism. The individuals who met inclusion criteria and were diagnosed with PCOS on ultrasonography were considered in the case group, and those who were not diagnosed with any disease were included in the control group. The individuals in the control group were apparently healthy individuals. The baseline information and biochemical parameters were compared between the individuals in both groups. The data collection was performed over 1 year between November 20, 2017, and November 25, 2018.
Inclusion and exclusion criteria
The individuals met eligibility criteria if they were aged 18 years and older, body mass index (BMI) between 20 and 35 irrespective of sociodemographic aspects. The individuals with pregnancy reported as hypertensive or diabetic were excluded from the study.
Data collection and diagnosis
The general information was collected from the subjects were age, BMI, marital status, history of infertility, menstruation categorized as regular/irregular, hirsutism, acne, and alopecia through self-reported technique.
Diagnosis of the polycystic ovarian syndrome
The diagnosis of PCOS was established in line with the Rotterdam Consensus on Diagnostic Criteria for PCOS. The revised diagnostic criteria of PCOS were in 2003 were oligo or anovulation, clinical and biochemical signs of hyperandrogenism, and polycystic ovaries, and exclusion of other etiologies (congenital adrenal hyperplasia, androgen-secreting tumors, and Cushing's syndrome). [9] A 5 cc of venous blood was taken from each patient for measurements of biochemical parameters. The biochemical measurements were performed at the laboratory of Duhok Maternity Hospital.
Statistical methods
The descriptive purposes of the study were presented in mean and standard deviation or frequency and percentage. The prevalence of hirsutism, menstruation regularity, acne, and alopecia was presented in frequency and percentage. The difference in baseline information between the subjects in PCOS and healthy groups were examined in the independent t-test, Chi-square, or Fishers' exact tests. The difference in biochemical parameters between two study groups was examined either in independent t-test or Mann-Whitney U-test. The significant difference was determined in a P < 0.05. The statistical calculations were performed in Statistical Package for Social Sciences version 24:00 (SPSS 24; IBM Corp; USA).
Ethical considerations
The ethical clearance of the present protocol was obtained from the Health Ethics Committee of the Kurdistan Board for Medical Specialties. The individuals were included in this study were not undergone any invasive medical procedure or surgery. In addition, informed verbal consent was taken from all patients before study inclusion.
results
Of the total 113 individuals included in the study, 70 (64.92%) of them were diagnosed as PCOS, and the remaining 43 individuals (38.05%) were apparently healthy. The PCOS patients were significantly younger than the healthy controls; 26.57 versus 33.51, P < 0.001. Besides, the PCOS patients were more likely to be single (31.4%) compared to the healthy controls (4.7%; P = 0.001). The PCOS patients were more likely to have irregular menstruation (81.4%) compared to healthy controls (4.7%; P < 0.001). While the individuals in both PCOS and healthy were not different in BMI (26.07 vs. 27.32; P = 0.429), a history of infertility (45.7% vs. 44.2%; P = 0.874), acne (P = 0.287), and alopecia (P = 1.00) [ Table 1 ].
The comparison of biochemical parameters between PCOS and healthy groups was shown in Table 2 . The analysis showed that patients in PCOS had a significantly lower level of Vitamin D (14.16 vs. 17.83 ng/ml; P = 0.010), and a higher level of serum prolactin (23.22 vs. 17.66 IU/L; P = 0.046) and thyroid-stimulating hormone (2.50 vs. 1.72; P = 0.004), respectively. However, there was no significant difference in random blood sugar (P = 0.168), follicle-stimulating hormone (P = 0.243), serum testosterone (P = 0.197), T3 (P = 0.250), T4 (P = 0.136), and luteinizing hormone (P = 0.735).
dIscussIon
The aim of the present investigation was to compare the Vitamin D level between the persons who were diagnosed with PCOS compared to a sample population of apparently healthy controls. The study found that the patients had a significantly lower level of Vitamin D. Furthermore, they were more likely to have irregular menstruation.
The association between Vitamin D levels and various PCOS symptoms including IR, hirsutism, and infertility have been documented in the literature. [10] [11] [12] [13] Pal et al. [12] explored the association between Vitamin D status and diagnosis of ovulatory disturbances and PCOS in a population of otherwise healthy infertile women in a cross-sectional study. They found 7% of persons with normal Vitamin D (>30 ng/ml) only in their study individuals. There were a significantly lower serum Vitamin D levels in women with ovulatory disturbances and PCOS compared to those with other infertility etiologies. Interestingly, they found that each unit increase in Vitamin D level was attributed to reducing the likelihood of PCOS diagnosis by 96% (P = 0.015), and for ovulatory infertility by 87% (P = 0.038).
Yılmaz et al. [14] determined the relation of serum 25-OHD levels to hormonal, clinical, and metabolic profile in patients with and without PCOS. In this regard, they included 48 normal-weight women with PCOS, 36 overweight women with PCOS, and 56 normal-weight control in the study. The blood samples were taken in the follicular phases between days 2 and 5 of the menstrual cycle following an overnight fast. They found that normal and overweight women with PCOS had a lower level of circulating 25-OHD levels compared to normal-weight controls. The levels of 25-OHD were reported to associate negatively with waist circumference, waist-to-hip ratio, free testosterone, and modified Ferriman-Gallwey scores.
The literature reported that Vitamin D deficiency in women with PCOS is between 67% and 85%, with a serum concentration of 25OHD <20 ng/ml. [7] The high prevalence of Vitamin D deficiency has been associated with metabolic syndrome, which may have a great effect on public health. [15] Low Vitamin D levels may escalate the PCOS symptoms, such as ovulatory, menstrual irregularities, infertility, IR, hyperandrogenism, and obesity. In addition, it elevates the risk of cardiovascular diseases. [16] Vitamin D supplementation lowers the abnormally elevated serum levels of anti-Müllerian hormone and raises serum soluble anti-inflammatory receptor for advanced glycation end-products in Vitamin D-deficient women with PCOS. [17] Particular, Vitamin D and calcium supplementation along with metformin therapy in women diagnosed with PCOS could lead to the beneficial impacts on menstrual regularity and ovulation. [17] The present study found that patients with PCOS were more likely to have irregular menstruation compared to healthy controls. Irregular menstruation has been reported to be the risk factor of PCOS in the literature as well. For instance, Shan et al. [18] explored the risk factors of PCOS in 285 cases of PCOS in comparison with 580 healthy controls in a case-control study. The menstrual irregularity of mother (odds ration [OR]: 2.557) was found to be one of the risk factors for PCOS. Other risk factors were a family history of infertility Majority of PCOS patients experience the onset of irregular menstruation as adolescence, and endocrine dyscrasia along any part of the hypothalamic-pituitary-gonadal axis may result in irregular menstruation and anovulation. [19] Besides, the irregular menstruation of the mother has been shown to contribute to a higher risk of PCOS of the daughter. [20] The exact reason for PCOS is inconclusive owing to its complexity. The literature has reported the interaction between genetic and environmental factors as the possible risk factors. [21] 
Strength and limitation of the study
The strong point of the study could be traced in its design and the strict inclusion, and exclusion criteria were applied to the subjects in both the study groups. However, the study was not exempt from the limitation. The difference in findings reported in the present investigation with those reported in the literature may back to the different diagnostic criteria of PCOS or various geographic locations.
conclusIon
The present study suggests that patients with PCOS were more likely to have irregular menstruation and a lower level of Vitamin D compared to apparently healthy controls. The early screen, diagnosis, and treatment of PCOS are recommended to decrease the incidence rate in this region.
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